Daniel Bouzard
Bristol-Myers Squibb
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Daniel Bouzard.
Journal of Medicinal Chemistry | 1989
Daniel Bouzard; P. Di Cesare; Munir Essiz; Jean-Pierre Jacquet; Philippe Remuzon; Abraham Weber; T. Oki; M. Masuyoshi
A number of 7-substituted-1-tert-butyl-6-fluoroquinolone-3-carboxylic acids and 7-substituted-1-tert-butyl-6-fluoro-1,8-naphthyridine-3-carboxylic acids have been prepared and tested for antibacterial activities. Among those the 7-aminopyrrolidinyl 20b and the 7-diazabicyclo naphthyridine 18b are the most potent compounds in vitro and in vivo. Physicochemical data and acute toxicity are also discussed. Compound 18b, BMY 40062, exhibits the most favorable overall properties, considering in vitro and in vivo microbiological activity, its low toxicity, and pharmacokinetic profile, and was selected for clinical evaluation.
Tetrahedron-asymmetry | 1997
Pascale Moreau; Munir Essiz; Jean-Yves Mérour; Daniel Bouzard
Abstract An efficient and enantiospecific synthesis of substituted 1,2-diphenylethylamines 5 from benzaldehydes is described using a recyclable chiral auxiliary.
ChemInform | 1990
Daniel Bouzard
Nalidixic acid was first introduced in therapy in 1963, about 15 years later a new generation of quinolones with broader spectrum of activity appeared: the fluoroquinolones; since then about 6000 new analogs have been disclosed and about 20 derivatives are marketed or in advanced development.
Tetrahedron | 1998
Claire Clémencin-Le Guillou; Philippe Remuzon; Daniel Bouzard; Jean-Charles Quirion; Sylviane Giorgi-Renault; Henri-Philippe Husson
Abstract Ethyl 2-ethenyl-6,7-methylenedioxy-1,2,3,4,-tetrahydro-1-(3′,4′,5′-trimethoxyphenyl)-4-oxoquinoline-3-carboxylate 1 was prepared by the reaction of vinylcuprate on ethyl 1,4-dihydro-6,7-methylenedioxy-1-(3′,4′,5′-trimethoxyphenyl)-4-oxoquinoline-3-carboxylate 9. Different quinolones and a tetrahydro-4-oxoquinoline have been obtained by oxidation of 1. Depending on the reagent, the initial addition occurs either at only one of the reactive functions, namely the vinyl double bond or the enolate, or at both. New unexpected 1,2-dihydroquinolines were synthesized in attempts at protecting the diol obtained by reduction of 1.
Tetrahedron-asymmetry | 1996
Philippe Remuzon; Christian Dussy; Jean-Pierre Jacquet; Pascale Roty; Daniel Bouzard
Abstract An efficient and stereocontrolled preparation of the (2 S ,3 R )-1,2-acetonide 15 , from hydrazone 10 , leading to a (D)-phenylalaninol derivative, potentially useful for the design of HIV protease inhibitors, is described.
Tetrahedron Letters | 1995
Philippe Remuzon; Christian Dussy; Jean-Pierre Jacquet; Maxime Soumeillant; Daniel Bouzard
Abstract Protection of the benzylic position of 4-methylaminosulfonylmethylphenyl hydrazine 6 with a 4-hydroxy-2-methyl-3(2 H )-isothiazolone-1,1-dioxide group allowed the preparation of indole 3 without formation of side-product.
Tetrahedron Letters | 1991
Jean-Pierre Jacquet; Daniel Bouzard; Jean-René Kiechel; Philippe Remuzon
Abstract Diprotected 3,6-diazabicyclo [3.2.0] heptane has been prepared by an highly efficient process. Selective deprotection, followed by condensation with 7-halogenoquinolones led to the naphthyridones 10 and 13 and the quinolone 14 .
Tetrahedron | 1995
Philippe Remuzon; Daniel Bouzard; Pierre Dicesare; Munir Essiz; Jean-Pierre Jacquet; Andrei Nicolau; Alain Martel; Marcel Menard; Carol Bachand
Abstract An efficient and stereocontrolled preparation of the key a/etidinone-acid 5a is described.
European Journal of Medicinal Chemistry | 1993
Philippe Remuzon; Daniel Bouzard; C Clemencin; Christian Dussy; Jean-Pierre Jacquet; J Fung-Tome; R. E. Kessler
Abstract The synthesis and the antimicrobial activities of chiral (1 R ,4 R ,7 S )- and (1 S ,4 S ,7 S )-[7-methyl-2,5-diazabicyclo[2.2.1]-heptan-2-yl] analogs of BMY 40062 are reported. The new derivatives have been found to be less active in vitro but as active in vivo (im) than BMY 40062. The 1 R ,4 R ,7 S substituent seems promising for the design of powerful new antibiotics.
Tetrahedron | 1997
Philippe Remuzon; Maxime Soumeillant; Christian Dussy; Daniel Bouzard
Abstract The synthesis of α-substituted N-[((2S)-2-hydroxy-2-phenyl)-ethyl]-2-phenylglycine derivatives is reported. The key step of the sequence is the highly diastereoselective alkylation of (6R)-2,3,5,6-tetrahydro-3,6-diaryl-N-[(2′R)-(2′-methyl)phenylmethyl]-4H-1,4-oxazin-2-ones after deprotonation with t-BuOK. Opening of the resulting oxazinone with ethanolic KOH, followed by hydrogenolysis of the corresponding N-[(2R)-(2-methyl)phenylmethyl] compound to furnish the expected 2-phenylglycine derivative, is also described.